Sterna Biologicals

Sterna Biologicals, founded in Marburg, Germany, focuses on developing innovative therapies for dysregulated type-2 immunity, which is linked to chronic inflammatory conditions such as asthma. The company's core mission is to improve the quality of life for individuals suffering from these conditions by offering targeted biological treatments. Their vision is to lead in the field of immunological research and provide effective solutions for chronic inflammation.

Notable figures associated with Sterna Biologicals include experts in immunology and chronic inflammatory diseases. The company has attracted significant investment from leading biotech investors, enabling it to advance its research and development efforts. Key achievements include the successful development of promising therapeutic candidates and securing patents for their unique treatment approaches. Sterna Biologicals has made a substantial impact on the biotech industry by addressing unmet medical needs in chronic inflammatory diseases.